Mather Group’s Integra LifeSciences IART Stock Holding History

Mather Group’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-79	Closed	-$2.8K	–	1926
2024 Q2	$2.8K	Buy	79 +4	+5%	+$119	﹤0.01%	1794
2024 Q1	$3.27K	Buy	+75	New	+$3K	﹤0.01%	1439

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mather Group's IART Position: Q3 2024 in Review

Mather Group sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 79 shares — an estimated $2.8K sold.

Mather Group first reported a position in IART in Q1 2024 and held it in 2 quarters. The position peaked at $3.27K in Q1 2024. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

Mather Group reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
Mather Group sold 79 Integra LifeSciences shares in Q3 2024, an estimated $2.8K.
Mather Group first reported a position in Integra LifeSciences in Q1 2024 and held it in 2 quarters.
Mather Group's Integra LifeSciences position peaked at $3.27K in Q1 2024.
225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Mather Group's 13F filing for Q3 2024, filed 7 Oct 2024.